TY - JOUR
T1 - Association Between Quality of Life Questionnaire at Diagnosis and Survival in Patients With Lung Cancer
AU - Hong, Yu Jin
AU - Han, Solji
AU - Lim, Jeong Uk
AU - Kang, Hye Seon
AU - Kim, Sung Kyoung
AU - Kim, Jin Woo
AU - Lee, Sang Haak
AU - Kim, Seung Joon
AU - Yeo, Chang Dong
N1 - Publisher Copyright:
© 2023 The Author(s)
PY - 2023/7
Y1 - 2023/7
N2 - Background: Patients with lung cancer experience considerable symptom burden, which can decrease patients’ QOL. Our aim was to investigate the association between QOL questionnaire at diagnosis and survival of lung cancer. Patients and Methods: This was a multicenter study of lung cancer patients at 7 medical centers of the Catholic University of Korea that responded to a quality of life questionnaire between December 1, 2017 and December 31, 2020. We analyzed 5 functional (physical, role, emotional, cognitive, and social functioning) and nine symptom (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties) scales and examined their associations with survival. A Cox proportional hazards model was used to evaluate the prognostic value. Results: In total, 1297 lung cancer patients were enrolled. The results of multivariable analysis showed that female, younger age, never smoker, stage I or II cancer, higher physical functioning, and emotional functioning were statistically significant favorable predictors for survival. On subgroup analysis according to early (stage I and II) or advanced (stage III or IV) stage, higher physical functioning and emotional functioning were each found to be favorable prognostic factors for survival. Meanwhile, fatigue, pain, insomnia, and financial difficulties were found to be associated with low scores on the emotional functioning scale; fatigue, pain, dyspnea, and financial difficulties were associated with low scores on the physical functioning scale. Conclusion: Assessing the physical functioning and emotional functioning scales of QOL questionnaire items at diagnosis can help clinicians predict the survival of patients with lung cancer.
AB - Background: Patients with lung cancer experience considerable symptom burden, which can decrease patients’ QOL. Our aim was to investigate the association between QOL questionnaire at diagnosis and survival of lung cancer. Patients and Methods: This was a multicenter study of lung cancer patients at 7 medical centers of the Catholic University of Korea that responded to a quality of life questionnaire between December 1, 2017 and December 31, 2020. We analyzed 5 functional (physical, role, emotional, cognitive, and social functioning) and nine symptom (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties) scales and examined their associations with survival. A Cox proportional hazards model was used to evaluate the prognostic value. Results: In total, 1297 lung cancer patients were enrolled. The results of multivariable analysis showed that female, younger age, never smoker, stage I or II cancer, higher physical functioning, and emotional functioning were statistically significant favorable predictors for survival. On subgroup analysis according to early (stage I and II) or advanced (stage III or IV) stage, higher physical functioning and emotional functioning were each found to be favorable prognostic factors for survival. Meanwhile, fatigue, pain, insomnia, and financial difficulties were found to be associated with low scores on the emotional functioning scale; fatigue, pain, dyspnea, and financial difficulties were associated with low scores on the physical functioning scale. Conclusion: Assessing the physical functioning and emotional functioning scales of QOL questionnaire items at diagnosis can help clinicians predict the survival of patients with lung cancer.
KW - EORTC QLQ-C30
KW - Emotional functioning
KW - Physical functioning
KW - Prognosis
KW - Symptom
UR - https://www.scopus.com/pages/publications/85152545348
U2 - 10.1016/j.cllc.2023.03.007
DO - 10.1016/j.cllc.2023.03.007
M3 - Article
C2 - 37061414
AN - SCOPUS:85152545348
SN - 1525-7304
VL - 24
SP - 459
EP - 466
JO - Clinical Lung Cancer
JF - Clinical Lung Cancer
IS - 5
ER -